From medicinal plant knowledge to standardized pharmaceutical development.
Curaem's development approach is based on reverse pharmacology: beginning with medicinal plant knowledge, then applying modern validation including plant authentication, phytochemical analysis, marker-component selection, biological assays, hepatoprotective models, and clinical development planning.
A staged pathway from plant to candidate.
Four pillars of validation.
Botanical standardization
Plant authentication, phytochemical characterization, heavy metal and sterility screening.
Biological validation
Anti-HBV, antioxidant, cytotoxicity, and biomarker assays.
Hepatoprotective research
Preclinical evaluation across liver injury models including fibrosis, cirrhosis, and NAFLD.
Development readiness
Data packaging, clinical protocol planning, regulatory strategy, and manufacturing readiness.
Rigor at every step — from cultivation to formulation.
Botanical-derived pharmaceutical development requires rigorous control of raw materials, marker components, cultivation conditions, and manufacturing consistency. Curaem's strategy is built on controlled cultivation and quality-standardized production planning.
Qualified scientific and strategic partners may request the detailed scientific package under NDA.
Curaem's product candidates are investigational and have not been approved by any regulatory authority. This page is intended for scientific and partnership information only and does not provide medical advice.
Request the detailed scientific data package.
Qualified scientific and strategic partners may request the extended data package under NDA.